semaglutide dietary recommendations Integrated nutritional-pharmacological strategy for obesity management What are you eating while

Clinical trials tracking patients post-discontinuation reveal weight loss typically returns within 3-6 months, with the steepest gains occurring in the first 12 weeks

10.1038/sj.jim.2900590 J

Secondary outcomes related to treatment satisfaction, well-being, and lifestyle

The guidance emphasized post-marketing surveillance informed by pre-marketing safety signals, moving away from a rigid one-size-fits-all model

It is also important to review any medications that may contribute to constipation, such as opioids, anticholinergics, or iron supplements

Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2020